Shuttle Pharmaceuticals Holdings, Inc. Share Price
NASDAQ: SHPH | Micro CapShuttle Pharmaceuticals Holdings, Inc. Stock Performance
Open $3.86 | Prev. Close $3.55 | Circuit Range N/A |
Day Range $3.86 - $4.50 | Year Range $0.40 - $6.15 | Volume 1,978 |
Average Traded $4.33 |
Shuttle Pharmaceuticals Holdings, Inc. Share Price Today
As of 5 August 2026, Shuttle Pharmaceuticals Holdings, Inc.'s share price is $4.33. The stock opened at $3.86, compared to its previous close of $3.55. During today's trading session, Shuttle Pharmaceuticals Holdings, Inc.'s share price traded between $3.86 and $4.50, with an average price of $4.18. Over the past 52 weeks, the stock has recorded a high of $6.15 and a low of $0.40. In terms of performance, Shuttle Pharmaceuticals Holdings, Inc.'s share price has risen by 320.87% over the last six months and is up 30.57% on a year-on-year basis.
Shuttle Pharmaceuticals Holdings, Inc. Share Price Chart
Shuttle Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $7.10M | PE Ratio (TTM) -0.61 | Dividend Yield N/A |
EPS (TTM) $-7.16 | Revenue (TTM) N/A | Return On Equity (TTM) -519.94% |
Profit Margin N/A | Debt to Equity 3.53 | Quarterly Earnings Growth YoY 37.97% |
Shuttle Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Shuttle Pharmaceuticals Holdings, Inc. Annual Profit & Loss
All figures in USD
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $3.29 | $4.50 | +21.62% |
Jul 2026 | $3.10 | $3.70 | +16.72% |
Jun 2026 | $0.54 | $3.17 | +502.66% |
May 2026 | $1.11 | $0.53 | -48.68% |
Apr 2026 | $0.70 | $1.02 | +55.30% |
Mar 2026 | $0.91 | $0.66 | -35.92% |
Feb 2026 | $1.90 | $1.03 | -49.14% |
Jan 2026 | $1.86 | $2.02 | +18.42% |
Dec 2025 | $1.40 | $1.71 | +18.75% |
Nov 2025 | $3.40 | $1.44 | -51.52% |
Oct 2025 | $3.69 | $2.97 | -24.43% |
Sep 2025 | $3.50 | $3.93 | +18.37% |
SHPH Share Price FAQs
What is Shuttle Pharmaceuticals Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Shuttle Pharmaceuticals Holdings, Inc. stock?
What is SHPH's market capitalisation today?
What is SHPH's net income for the last quarter?
What is the 5 year returns of SHPH?
What is the high & low stock price of SHPH today?
Can I buy SHPH shares in India?